Abstract:
Embodiments of the invention provides a method for detecting one or more biomarkers derived from a body fluid, comprising performing one or more assays for the biomarkers from a sample of the body fluid, whereby the sample is previously preserved on a solid support; wherein a change in the biomarkers provides an indication of a biological event in the brain. The invention also provides related methods for identifying a person as being at risk of dementia or Alzheimer's disease, monitoring a person for the onset or progression of dementia or Alzheimer's disease, evaluating the effectiveness of a potential pharmaceutical agent.
Abstract:
The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID No. 1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55 °C for 10 minutes in a buffer consisting of 10 mM Tris-HCI, pH 8.5 at 25 °C, 50 mM KCI and 5 mM MgCI 2 ; (ii) is substantially specific for single stranded DNA; and (iii) has a 3'-5' exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used. The invention still further provides nucleic acids encoding said exonuclease or an enzymatically active fragment thereof and kits or compositions comprising the same.
Abstract:
The present invention provides the use of RNA removal to initiate protein aggregation of a plurality of proteins in a cell or cell lysate. This may be used to create an in vitro model of a disease, such as a neurodegenerative disease. The present invention also provides a method for determining the efficacy of a potential anti-protein aggregation agent comprising the following steps: i) using RNA removal to initiate the aggregation of a protein in a cell or cell lysate, ii) treating the cell or cell lysate with the potential anti-protein aggregation agent before, after or during RNA removal; and iii) comparing protein aggregation in equivalent samples with and without step ii) treatment in which a decrease in protein aggregation associated with step ii) treatment indicates that the potential anti-protein aggregation agent is effective in preventing and/or reversing protein aggregation.
Abstract:
The invention relates to the field of detecting and measuring misfolded proteins/peptides. In particular, the invention relates to the detection and measurement of misfolded proteins/peptides in bodily fluids and on cell surfaces and tissues of persons and mammals, to the detection of misfolded proteins/peptides in test reagents for research purposes and/or diagnostic purposes and in medications or medication additives, and to the removal of misfolded proteins/peptides from test reagents for research purposes and/or diagnostic purposes and from medications or medication additives. The invention further relates to detection substances and methods for detecting biofilms, to a method for testing the hemocompatibility of materials and for optimizing medical products, to reagents for cultivating microorganisms in order to make diagnostics and the quality control of biopharmaceuticals easier, and to detection substances for screening for precursors of amyloids, which can be used for technical purposes.
Abstract:
Compositions, methods and systems are provided for the isolation of polymerase-nucleic acid complexes. Complexes can be separated from free enzyme by using hook molecules to target single stranded regions on the nucleic acid. Active complexes can be isolated from mixtures having both active and inactive complexes by initiating nucleic acid synthesis so as to open up a portion of a double stranded region rendering that region single stranded. Hook molecules are targeted to bind the sequences that are thus exposed. The hook molecules bound to active polymerase-nucleic acid complex are isolated, and the active polymerase-nucleic acid complexes released. Also disclosed are compositions, devices, and methods for loading molecules-of-interest onto a substrate by contacting beads having molecules-of-interest attached to them with the substrate, for example by providing a field that brings the beads into proximity or contact with the substrate and moves the beads with respect to the substrate. Such molecules-of-interest can be deposited onto substrates for single-molecule analysis.
Abstract:
The present invention relates to a method of identifying a molecule that modulates the activity or expression of endonuclease G for the treatment of a disease selected from a hypertension associated and a hypertrophy associated disease. The present invention also provides a method for determining the level of endonuclease G activity and a method for treating or monitoring a hypertension associated and/or a hypertrophy associated disease.
Abstract:
An extraction medium for use in detection of a protein in a biological sample is described. The extraction medium contains a combination of reagents, including a nuclease, that aid in nuclear protein extraction from the biological sample. The medium is particularly suited for use in commercially-available rapid diagnostic assays, where the medium improves sensitivity of the assay to the presence of viral nuclear proteins. Kits comprising the extraction medium and methods of using the extraction medium are also described.
Abstract:
La présente invention a pour objet l'utilisation, en cosmétique et en thérapeutique, d'au moins une protéine antimicrobienne de la famille des ribonucléases, la ribonucléase 7, ou de polypeptides dérivés de cette protéine, notamment à titre de marqueur pour l'évaluation d'un état de l´épiderme. Elle vise en outre l'utilisation d'au moins un polypeptide conforme à l'invention, d'au moins une séquence d'acides nucléiques codant pour un polypeptide conforme à l'invention, ou d'au moins un agent modulateur de l'expression ou de l'activité, notamment biologique, dudit polypeptide ou de son interaction avec un élément de la matrice extracellulaire, pour la préparation de compositions visant à prévenir et/ou traiter des troubles cutanés.
Abstract:
The present invention relates to a method for the in vitro diagnosis of an Aspergillus infection by determining in the serum or plasma sample of a subject the quantity of antibodies directed against a combination of at least two of the ribonuclease (RNU), catalase (CA) and dipeptidylpeptidase V (DPPV) Aspergillus antigens. The invention also relates to a diagnostic kit comprising said combination.